EcoDrugPlus

Exportin 1

Ensembl ID : ENSOTSG00005009013
Gene Symbol: XPO1
3 Cross references
218 Possible Orthologues:

Exportin 1

Ensembl ID : ENSOTSG00005015509
Gene Symbol: XPO1
1 Cross references
209 Possible Orthologues:

Farnesyl Diphosphate Synthase (Farnesyl Pyrophosphate Synthetase, Dimethylallyltranstransferase, Geranyltranstransferase)

Ensembl ID : ENSOTSG00005021232
Gene Symbol: FDPS
1 Cross references
261 Possible Orthologues:

Farnesyl Pyrophosphate Synthase-Like

Ensembl ID : ENSOTSG00005019945
Gene Symbol: LOC112242342
3 Cross references
261 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSOTSG00005028057
Gene Symbol: FDFT1
3 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSOTSG00005047388
Gene Symbol: FNTA
1 Cross references
215 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSOTSG00005038986
Gene Symbol: FNTB
1 Cross references
201 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSOTSG00005021877
Gene Symbol: FGFR1
1 Cross references
198 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSOTSG00005013520
Gene Symbol: FGFR1
1 Cross references
197 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-A-Like

Ensembl ID : ENSOTSG00005043158
Gene Symbol: LOC112262942
3 Cross references
203 Possible Orthologues:

Fibroblast Growth Factor Receptor 1a

Ensembl ID : ENSOTSG00005042346
Gene Symbol: FGFR1A
1 Cross references
203 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSOTSG00005047148
Gene Symbol: FGFR2
3 Cross references
213 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).